Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature.

Soni, Kishan; Kumar, Tarun; Pandey, Manoj

Soni, Kishan; Kumar, Tarun; Pandey, Manoj.

Affiliation

Soni K; Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.
Kumar T; Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.
Pandey M; Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India. manojpandey66@gmail.com.

World J Surg Oncol ; 18(1): 153, 2020 Jul 04.

Article de En | MEDLINE | ID: mdl-32622356

Sujet(s)
Mots clés

Chemotherapy; Erlotinib; Gallbladder cancer; Gemcitabine; Tyrosine kinase inhibitors

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vésicule biliaire / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Female / Humans / Middle aged Langue: En Journal: World J Surg Oncol Année: 2020 Type de document: Article Pays d'affiliation: Inde Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google